23rd Apr 2026 13:15
At Swedencares Annual General Meeting, on April 23rd, 2026, the following decisions were made:
Adoption of the income statement and balance sheetThe Annual General Meeting decided on the adoption of the income statement and balance sheet as well as consolidated income statement and consolidated balance sheet for the financial year 2025. Dispositions regarding the Company´s profitThe Annual General Meeting decided on a dividend of 0.28 SEK per share, corresponding to a total of 44,755,468 SEK. The recording date for the right to receive dividends is decided to be April 27th, 2026. Dividends are expected to be paid through Euroclear Sweden AB on April 30th, 2026. Discharge from liability towards the Company for the Board members and the CEOThe Annual General Meeting decided to grant discharge from liability towards the Company to the Board members and the CEO for the year 2025. Determination of fees to the Board and AuditorThe Annual General Meeting decided on Board fees of a total of 1,700,000 SEK to be distributed with 700,000 SEK to the Chairman and 250,000 SEK each to other members elected by the Annual General Meeting, except representatives for Symrise Group. For committee work, to the members appointed by the board: 125,000 SEK to the chairman and 50,000 SEK to member of the audit committee. No compensation is paid to the chairman of the remuneration committee and the other members of the committee. Auditor fee according to approved bill. Election of Board members, Chairman of the Board, and auditorThe Annual General Meeting decided on re-electing the board members Johan Bergdahl, Thomas Eklund, Sara Brandt, Ulrika Valassi and Isabelle Guiller. Also new electing Diego Maurizio and Thomas Thomsen. The Annual General Meeting decided to new elect Thomas Eklund as Chairman of the Board. The Annual General Meeting decided to re-elect Deloitte AB with Maria Ekelund as principal auditor for the period until the end of the Annual General Meeting of 2027. Principles for the appointment of a nomination committeeThe Annual General Meeting decided to adopt principles for the appointment of a nomination committee meaning mainly that the three (3) largest shareholders of the company per September 30th have the right to appoint a member to the nomination committee. Authorization for the Board of Directors to resolve on the issue of sharesThe Annual General Meeting decided to authorize the Board of Directors to, on one or more occasions during the period until the next Annual General Meeting, decide to increase the company's share capital by a maximum of 17 760 106 shares through a new issue of shares. The Board shall be able to decide on the issue of shares with deviation from the shareholders' preferential rights and/or with a provision on non-cash, set-off or otherwise with conditions in accordance with Chapter 2, § 5, second paragraph 1-3 and 5 of the Companies Act. Resolution on authorizing the Board of Directors to carry out synthetic buybacks of own shares The annual general meeting decided, in accordance with the proposal from the board, on authorizing the Board of Directors to carry out synthetic buybacks of own shares
Resolution on authorizing to decide on the acquisition and disposal of the own sharesThe annual general meeting decided, in accordance with the proposal from the board, on authorizing to decide on the acquisition and disposal of the own shares
For more information, please contact:
H¥kan Lagerberg, CEO SwedencarePhone: +46 (0)73 517 01 70Email: [email protected]Jenny Graflind, CFO SwedencarePhone: +46 (0)73 944 85 54Email: [email protected]
FNCA is the Certified Adviser of the Company
Please visit the Company homepage www.swedencare.com
About Swedencare
Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.
With headquarters in Malm¶, our products are sold in approximately 70 countries through online channels, pet stores, veterinarians, and FDMC. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.
Attachments
Swedencare AB (publ) Press release from the Annual General Meeting 2026
Related Shares:
Swedencare Ord